Literature DB >> 20352536

Polymer percolation threshold in HPMC extended release formulation of carbamazepine and verapamil HCl.

Tamara Gonçalves-Araújo1, Ali R Rajabi-Siahboomi, Isidoro Caraballo.   

Abstract

The principles of the percolation theory were applied to further understand and design hydroxypropyl methylcellulose (HPMC) extended release matrix tablets containing carbamazepine and verapamil HCl. This statistical theory studies disordered or chaotic systems where the components are randomly distributed in a lattice. The application of this theory to study the hydration and drug release of hydrophilic matrices allows describing the changes in hydration and drug release kinetics of swellable matrices. The aim of this work was to study and develop extended release matrix formulations for carbamazepine and verapamil HCl, containing hypromellose (HPMC, METHOCEL Premium K100M CR) as rate controlling polymer using the concepts of percolation theory. The knowledge of the percolation threshold of the components of the matrix formulations contributes to improve their design. First, reducing the time to market and second, avoiding to formulate in the nearby of the percolation threshold, which will result in a lower variability. Therefore these formulations will be more robust when they are prepared at industrial scale. The HPMC percolation threshold for drugs with very different water solubilities was determined and it was shown that there was no significant influence of drug solubility on the HPMC critical concentration threshold (excipient percolation threshold). This may be related to the versatility and broad functionality of the swelling hydrophilic matrices.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352536      PMCID: PMC2902342          DOI: 10.1208/s12249-010-9408-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  11 in total

1.  Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  2000-06

2.  Relationship between drug percolation threshold and particle size in matrix tablets.

Authors:  I Caraballo; M Millan; A M Rabasco
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

3.  Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.

Authors:  Antonia Miranda; Mónica Millán; Isidoro Caraballo
Journal:  Int J Pharm       Date:  2006-01-30       Impact factor: 5.875

4.  Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.

Authors:  Antonia Miranda; Mónica Millán; Isidoro Caraballo
Journal:  J Pharm Sci       Date:  2007-10       Impact factor: 3.534

5.  Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.

Authors:  Inmaculada Fuertes; Antonia Miranda; Mónica Millán; Isidoro Caraballo
Journal:  Eur J Pharm Biopharm       Date:  2006-07-28       Impact factor: 5.571

6.  The role of the drug/excipient particle size ratio in the percolation model for tablets.

Authors:  M Millán; I Caraballo; A M Rabasco
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

7.  Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing.

Authors:  Nadia Passerini; Beatrice Perissutti; Beatrice Albertini; Dario Voinovich; Mariarosa Moneghini; Lorenzo Rodriguez
Journal:  J Control Release       Date:  2003-03-07       Impact factor: 9.776

8.  Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery.

Authors:  Antonia Miranda; Mónica Millán; Isidoro Caraballo
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-05       Impact factor: 1.645

9.  The influence of excipients on drug release from hydroxypropyl methylcellulose matrices.

Authors:  Marina Levina; Ali R Rajabi-Siahboomi
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

10.  Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.

Authors:  Tamara Gonçalves-Araújo; Ali R Rajabi-Siahboomi; Isidoro Caraballo
Journal:  Int J Pharm       Date:  2008-05-29       Impact factor: 5.875

View more
  2 in total

1.  Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC).

Authors:  P Zarmpi; T Flanagan; E Meehan; J Mann; N Fotaki
Journal:  AAPS J       Date:  2020-02-18       Impact factor: 4.009

2.  Single Layer Extended Release Two-in-One Guaifenesin Matrix Tablet: Formulation Method, Optimization, Release Kinetics Evaluation and Its Comparison with Mucinex® Using Box-Behnken Design.

Authors:  Amirhosein Morovati; Alireza Ghaffari; Lale Erfani Jabarian; Ali Mehramizi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.